Acknowledgments This study was supported by a postgraduate student research award from the Faculty of Science, University of Technology Sydney
The unexpected connection between diabetes medications and MCAS relief that's transforming patient care As a functional medicine physician who has dedicated my career to unraveling the mysteries of complex chronic conditions, I'm constantly searching for innovative approaches that address root causes rather than just symptoms
However, not all patients can access GLP-1s at the same pace
As lixisenatide is known to delay gastric emptying [14], a marked decrease in postprandial hyperglycemia was noted with lixisenatide [57,58], which is a characteristic property of the short-acting GLP-1 analogs [30]
Presented for research literature review only Bin Dayel FF (2025)
However, GSIS was decreased following oral but not intraperitoneal glucose administration in DIRKO compared to mice with just one of these receptors knocked out